OraSure Technologies, Inc. is a healthcare company based in the United States that focuses on developing, manufacturing, and distributing oral fluid diagnostic and collection devices. With a low ESG risk rating score of 16.4, the company specializes in providing rapid oral diagnostic tests and specimen collection devices for infectious diseases like HIV and HCV. OraSure Technologies also offers molecular solutions for collecting, stabilizing, and transporting genetic material for testing hereditary and infectious diseases, including COVID-19. Majority of its sales come from the molecular solutions segment, serving customers mainly in the United States.